CSF2 and neoplasm: A complex consisting of 10 kDa CS, PEI, and an expression vector for granulocyte macrophage-colony stimulating factor (GM-CSF) was able to deliver the plasmid into intraperitoneal and subcutaneous tumors in a syngeneic mouse model, and the released CSF inhibited tumor growth [108].